Lenvatinib Mesylate Intermediate CAS 205448-65-3 Bohloeki >98.0% (HPLC) Factory

Tlhaloso e Khutšoanyane:

Lebitso la lik'hemik'hale: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate

CAS: 205448-65-3

Bohloeki: >98.0% (HPLC)

Ponahalo: Bosoeu bo Bosoeu ho isa Bosehla

Bohareng ba Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate
Litlhaloso tse tšoanang 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Lenvatinib ea Hare 3
Nomoro ea CAS 205448-65-3
Nomoro ea KAtse RF-PI1973
Boemo ba Setoko Ka Setokong, Bokhoni ba Tlhahiso 50 MT / Selemo
Foromo ea limolek'hule C12H11NO4
Boima ba Molek'hule 233.22
Ntlha e belang 421.0±45.0℃
Botenya 1.267±0.060 g/cm3
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Phofo e Tletseng-Bosoeu ho isa ho Bosehla
Mokhoa oa Bohloeki / Analysis >98.0% (HPLC)
Tahlehelo ka ho Omisa <1.00%
Masalla a ho Ignition <0.50%
Litšila ka Kakaretso <2.00%
H-NMR E Ikamahanya le Sebopeho
Tekanyetso ea Teko Maemo a Khoebo
Tšebeliso Mekhatlo ea Meriana

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo

Melemo:

1

LBH:

Kopo:

Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) ke bohareng ba Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, e rekisoang ka lebitso la Lenvima har'a tse ling, ke moriana o thibelang mofetše bakeng sa ho alafa mefuta e itseng ea mofetše oa qoqotho le mefetše e meng hape.E entsoe ke Eisai Co. 'me e sebetsa e le multiple kinase inhibitor khahlanong le VEGFR1, VEGFR2 le VEGFR3 kinases.Lenvatinib e amohetsoe (ho tloha 2015) bakeng sa kalafo ea mofets'e oa qoqotho o fapaneng oo e ka bang o ipheta-pheta kapa oa metastatic, o tsoelang pele, o sa arabeleng kalafo ka radioactive iodine (radioiodine).Ka May 2016, US Food and Drug Administration (FDA) e ile ea e amohela (hammoho le everolimus) bakeng sa phekolo ea kankere ea kankere ea renal e tsoetseng pele ka mor'a phekolo e le 'ngoe ea pele ea anti-angiogenic.Setlhare sena se boetse se amohetsoe US le European Union bakeng sa kankere ea sebete ea hepatocellular e ke keng ea tlosoa ka ho buuoa ho bakuli ba sa kang ba fumana phekolo ea kankere ka molomo kapa ka ente.

Ngola molaetsa wa hao mona mme o re romele wona